Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,443
Closed -$312K 144
2025
Q4
$312K Sell
6,443
-235
-4% -$11.6K 0.09% 116
2025
Q3
$315K Sell
6,678
-164
-2% -$7.92K 0.09% 116
2025
Q2
$331K Buy
6,842
+185
+3% +$9.45K 0.1% 112
2025
Q1
$369K Buy
6,657
+406
+6% +$22K 0.12% 104
2024
Q4
$301K Buy
6,251
+352
+6% +$17.9K 0.09% 118
2024
Q3
$340K Buy
5,899
+1,092
+23% +$59K 0.1% 114
2024
Q2
$233K Buy
+4,807
New +$232K 0.07% 125

Other funds holding SNY

Bank of Stockton's SNY Position: Q1 2026 in Review

Bank of Stockton sold out of Sanofi (SNY) in Q1 2026, closing a stake of 6,443 shares — an estimated $312K sold.

Bank of Stockton first reported a position in SNY in Q2 2024 and held it in 7 quarters. The position peaked at $369K in Q1 2025. 743 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Bank of Stockton reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Bank of Stockton sold 6,443 Sanofi shares in Q1 2026, an estimated $312K.
  • Bank of Stockton first reported a position in Sanofi in Q2 2024 and held it in 7 quarters.
  • Bank of Stockton's Sanofi position peaked at $369K in Q1 2025.
  • 743 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Bank of Stockton's 13F filing for Q1 2026, filed 29 Apr 2026.